Adlai Nortye (NASDAQ:ANL) Trading Up 6.3% - Should You Buy?

Key Points

• Adlai Nortye shares rose 6.3% to $14.61 during midday trading, though volume was 83% below the average daily level.
• Analyst sentiment is generally positive, with five Buy ratings and one Sell rating producing a “Moderate Buy” consensus and an average price target of $24.25.
• Institutional ownership stands at 35.21%, with several hedge funds—including Boone Capital Management—recently establishing or expanding positions.

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL - Get Free Report) was up 6.3% during mid-day trading on Wednesday . The company traded as high as $14.66 and last traded at $14.61. Approximately 67,339 shares were traded during trading, a decline of 83% from the average daily volume of 397,252 shares. The stock had previously closed at $13.74.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Weiss Ratings reissued a "sell (e+)" rating on shares of Adlai Nortye in a research note on Tuesday, July 14th. Wall Street Zen raised Adlai Nortye from a "hold" rating to a "buy" rating in a research report on Saturday. Oppenheimer assumed coverage on Adlai Nortye in a report on Thursday, May 28th. They issued an "outperform" rating and a $32.00 price target on the stock. JonesTrading began coverage on Adlai Nortye in a research report on Thursday, May 14th. They issued a "buy" rating and a $22.00 price target for the company. Finally, Cantor Fitzgerald started coverage on Adlai Nortye in a research note on Monday, June 22nd. They set an "overweight" rating for the company. Five research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, Adlai Nortye currently has an average rating of "Moderate Buy" and an average price target of $24.25.

Adlai Nortye Price Performance

The firm's 50 day moving average is $11.91 and its 200 day moving average is $11.13. The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.65 and a current ratio of 9.55.

Institutional Trading of Adlai Nortye

Hedge funds and other institutional investors have recently made changes to their positions in the business. SmartHarvest Portfolios LLC increased its position in Adlai Nortye by 8.5% during the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company's stock valued at $113,000 after buying an additional 1,279 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Adlai Nortye during the first quarter worth about $457,000. Affinity Asset Advisors LLC acquired a new position in shares of Adlai Nortye during the first quarter valued at about $1,140,000. ADAR1 Capital Management LLC acquired a new position in shares of Adlai Nortye during the first quarter valued at about $816,000. Finally, Boone Capital Management LLC purchased a new position in shares of Adlai Nortye in the 2nd quarter valued at approximately $2,971,000. Hedge funds and other institutional investors own 35.21% of the company's stock.

About Adlai Nortye

Adlai Nortye Inc NASDAQ: ANL is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source